Denmark became at least the sixth European country to scale back the use of AstraZeneca’s COVID-19 vaccine after some people who received it developed blood clots.
Health officials say they’re investigating the cases, but there’s no evidence so far that the British drugmaker’s jab caused the clots.
The Danish Health and Medicines Authority halted the rollout of AstraZeneca’s jab for at least two weeks on Thursday following “severe cases” of blood clots in vaccinated people, one of which was related to a death.
Danish officials say they need to take time to probe those incidents even though there’s good evidence the AstraZeneca vaccine is safe and effective.
Magnus Heunicke, Denmark’s health minister, said it is not yet clear whether there’s a link between the shot and the blood clots. Danish officials are waiting for European Union authorities to investigate the potential link.
“Right now we need all the vaccines we can get. Therefore, putting one of the vaccines on pause is not an easy decision,” Søren Brostrøm, director of Denmark’s National Board of Health, said in a statement. “But precisely because we vaccinate so many, we also need to respond with timely care when there is knowledge of possible serious side effects.” Read Full Article >